Literatur
- 1
Bauer T, Britton P, Lomas D. et al .
Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic
telangiectasia.
J Hepatol.
1995;
22
586-590
- 2 Berendes J. HNO-Heilkunde in Praxis und Klinik. 2. Aufl. Georg-Thieme
Verlag 1979
- 3
Bergler W, Gotte K, Riedel F. et al .
Die Argon-Plasma-Koagulation in der Behandlung von hereditaren hamorrhagischen
Teleangiektasien der Nasenschleimhaut. (Argon plasma coagulation in treatment
of hereditary hemorrhagic telangiectasia of the nasal mucosa).
HNO.
1998;
46
228-232
- 4
Bergler W, Riedel F, Baker-Schreyer A. et al .
Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia.
Laryngoscope.
1999;
109
15-20
- 5
Boillot O, Bianco F, Viale J P. et al .
Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic
telangiectasia with hepatic involvement.
Gastroenterology.
1999;
116
187-192
- 6
Braverman I M, Keh A, Jacobson B S.
Ultrastructure and three-dimensional organization of the telangiectases of hereditary
hemorrhagic telangiectasia.
J Invest Dermatol.
1990;
95
422-427
- 7
Brohee D, Franken P, Fievez M. et al .
High-output right ventricular failure secondary to hepatic arteriovenous microfistulae.
Selective arterial embolization treatment.
Arch Intern Med.
1984;
144
1282-1284
- 8
Burke C M, Raffin T A.
Pulmonary arteriovenous malformations, aneurysms and reflections.
Chest.
1986;
89
771-772
- 9
Buscarini E, Buscarini L, Danesino C. et al .
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler
sonographic screening in a large family.
J Hepatol.
1997;
26
111-118
- 10
Caselitz M, Wagner S, Chavan A. et al .
Clinical outcome of transfemoral embolisation in patients with arteriovenous
malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler
disease).
Gut.
1998;
42
123-126
- 11
Gluckman J L, Portugal L G.
Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic
telangiectasia.
Laryngoscope.
1994;
104
1174-1177
- 12
Golding-Wood P H.
The role of arterial ligation in intractable epistaxis.
J Laryngol Otol.
1983;
8120-8122
(Suppl)
- 13
Gothlin J H, Nordgard K, Jonsson K. et al .
Hepatic telangiectasia in Osler’s disease treated with arterial embolization:
Report of 2 cases.
Eur J Radiol.
1982;
2
27-30
- 14
Guttmacher A E, Marchuk D A, White R I.
Hereditary hemorrhagic telangiectasia.
N Engl J Med.
1995;
333
918-924
- 15
Haitjema T, Disch F, Overtoom T T. et al .
Screening family members of patients with hereditary hemorrhagic telangiectasia.
Am J Med.
1995;
99
519-524
- 16
Haitjema T, Westermann C J, Overtoom T T. et al .
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights
in pathogenesis, complications, and treatment.
Arch Intern Med.
1996;
156
714-719
- 17
Hanes F M.
Multiple hereditary telangiectasee cause hemorrhage (herditary hemorrhagic telangiectasia).
Bull Johns Hopkins Hosp.
1909;
20
63-73
- 18
Jackson J E.
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: treatment
with embolization.
Radiology.
1999;
213
927-928
- 19
Jahnke V.
Zur Feinstriktur des Morbus Rendu-Osler-Weber. (Fine structure in Rendu-Osler-Weber’s
disease).
Arch Klin Exp Ohren Nasen Kehlkopfheilkd.
1971;
199
610-614
- 20
Johnson D W, Berg J N, Baldwin M A. et al .
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic
telangiectasia type 2.
Nat Genet.
1996;
13
189-195
- 21
Kjeldsen A D, Oxhoj H, Andersen P E. et al .
Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography
in patients with hereditary hemorrhagic telangiectasia.
Chest.
1999;
116
432-439
- 22
Lennox P A, Harries M, Lund V J. et al .
A retrospective study of the role of the argon laser in the management of epistaxis
secondary to hereditary haemorrhagic telangiectasia.
J Laryngol Otol.
1997;
111
34-37
- 23
Mager J J, Westermann C J.
Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia.
Arch Dermatol.
2000;
136
732-734
- 24
Maher C O, Piepgras D G, Brown R -DJ. et al .
Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic
telangiectasia.
Stroke.
2001;
32
877-882
- 25
Mathus-Vliegen E M.
Laser treatment of intestinal vascular abnormalities.
Int J Colorectal Dis.
1989;
4
20-25
- 26
Matsubara S, Manzia J L, ter Brugge K. et al .
Angiographic and clinical characteristics of patients with cerebral arteriovenous
malformations associated with hereditary hemorrhagic telangiectasia.
Am J Neuroradiol.
2000;
21
1016-1020
- 27
McAllister K A, Grogg K M, Johnson D W. et al .
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary
haemorrhagic telangiectasia type 1.
Nat Genet.
1994;
8
345-351
- 28
Neumann U P, Knoop M, Langrehr J M. et al .
Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation
of the hepatic artery and subsequent liver transplantation.
Transpl Int.
1998;
11
323-326
- 29
Ocran K, Rickes S, Neye H. et al .
Dopplersonographische Leberbefunde bei M Osler.
Ultraschall Med.
2001;
22
S38-S39
- 30
Odorico J S, Hakim M N, Becker Y T. et al .
Liver transplantation as definitive therapy for complications after arterial
embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia.
Liver Transpl Surg.
1998;
4
483-490
- 31
Olivieri C, Mira E, Delu G. et al .
Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected
Italian patients affected by hereditary haemorrhagic telangiectasia.
J Med Genet.
2002;
39
E39
- 32
Osler W.
On a family form of recurring epistaxis, associated with multiple telangiectases
of the skin and mucous membranes.
Bull Johns Hopkins Hosp.
1901;
12
333-?33
- 33
Piantanida M, Buscarini E, Dellavecchia C. et al .
Hereditary haemorrhagic telangiectasia with extensive liver involvement is not
caused by either HHT1 or HHT2.
J Med Genet.
1996;
33
441-444
- 34
Plauchu H, de Chadarevian J P, Bideau A. et al .
Age-related clinical profile of hereditary hemorrhagic telangiectasia in an
epidemiologically recruited population.
Am J Med Genet.
1989;
32
291-297
- 35
Porteous M E, Curtis A, Williams O. et al .
Genetic heterogeneity in hereditary haemorrhagic telangiectasia.
J Med Genet.
1994;
31
925-926
- 36
Radtke W E, Smith H C, Fulton R E. et al .
Misdiagnosis of atrial septal defect in patients with hereditary telangiectasia
(Osler-Weber-Rendu disease) and hepatic arteriovenous fistulas.
Am Heart J.
1978;
95
235-242
- 37
Reilly P J, Nostrant T T.
Clinical manifestations of hereditary hemorrhagic telangiectasia.
Am J Gastroenterol.
1984;
79
363-367
- 38
Rendu H J.
Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux.
Bull Soc Med Hop (Paris).
1896;
13
731-733
- 39
Sargeant I R, Loizou L A, Rampton D. et al .
Laser ablation of upper gastrointestinal vascular ectasias: long term
results.
Gut.
1993;
34
470-475
- 40
Saunders W H.
Epistaxis.
Minn Med.
1967;
50
849-854
- 41
Saunders W H.
Septal dermoplasty-ten years experience.
Trans Am Acad Ophthalmol Otolaryngol.
1968;
72
153-160
- 42
Shovlin C L, Guttmacher A E, Buscarini E. et al .
Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber
syndrome).
Am J Med Genet.
2000;
91
66-67
- 43
Shovlin C L, Hughes J M, Tuddenham E G. et al .
A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3.
Nat Genet.
1994;
6
205-209
- 44
Shovlin C L, Letarte M.
Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations:
issues in clinical management and review of pathogenic mechanisms.
Thorax.
1999;
54
714-729
- 45
Stockx L, Raat H, Caerts B. et al .
Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber
disease: a case report and review of the literature.
Eur Radiol.
1999;
9
1434-1437
- 46
Trotter J F, Suhocki P V, Lina J R. et al .
Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment
with transcatheter embolization.
Am J Gastroenterol.
1998;
93
1569-1571
- 47
Van Cutsem E, Rutgeerts P, Geboes K. et al .
Estrogen-progesterone treatment of Osler-Weber-Rendu disease.
J Clin Gastroenterol.
1988;
10
676-679
- 48
Vincent P, Plauchu H, Hazan J. et al .
A third locus for hereditary haemorrhagic telangiectasia maps to chromosome
12q.
Hum Mol Genet.
1995;
4
945-949
- 49
Weber F P.
Multiple heriditary developmental angiomata (telangiectases) of the skin and
mucous membranes associated with recurring haemorrhages.
Lancet.
1907;
2
160-162
- 50
Werner J A, Lippert B M, Geisthoff U W. et al .
Nd:YAG-Lasertherapie der rezidivierenden Epistaxis bei hereditarer hamorrhagischer
Teleangiektasie. (Nd:YAG laser therapy of recurrent epistaxis in hereditary
hemorrhagic telangiectasia).
Laryngorhinootologie.
1997;
76
495-501
- 51
White R I, Pollak J S, Wirth J A.
Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy.
J Vasc Interv Radiol.
1996;
7
787-804
- 52
Zentler-Munro P L, Howard E R, Karani J. et al .
Variceal haemorrhage in hereditary haemorrhagic telangiectasia.
Gut.
1989;
30
1293-1297
1 Herrn Prof. Dr. med. Dr. h.c. Walter Siegenthaler zum 80. Geburtstag
Dr. Kenneth Ocran
Universitätsklinikum Charité, Campus Mitte, Medizinische Klinik - Gastroenterologie/Hepatologie
10098 Berlin
Phone: +49/30/450514045
Fax: +49/30/450514939
Email: ocran@charite.de
